𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I/II study of cisplatin, 5-fluorouracil and α-interferon for recurrent carcinoma of the head and neck

✍ Scribed by Martin H. Huber; Mihran Shirinian; Scott M. Lippman; Isaiah W. Dimery; Robert A. Frankenthaler; Waun Ki Hong

Book ID
104986082
Publisher
Springer US
Year
1994
Tongue
English
Weight
571 KB
Volume
12
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin-5-fluorouracil chemotherapy fo
Cisplatin-5-fluorouracil chemotherapy for advanced inoperable squamous carcinoma of the head and neck
✍ Johnson, Jonas T. ;Mayernik, David G. ;Myers, Eugene N. ;Nolan, Teresa A. ;Schra 📂 Article 📅 1987 🏛 Wiley (John Wiley & Sons) ⚖ 368 KB 👁 2 views

Patients with locally advanced, inoperable squamous cell carcinoma of the head and neck were offered three courses of cisplatin and 96-h 5-fluorouracil (5-FU) infusion. Subsequent therapy included surgery when feasible, irradiation therapy, and a maintenance program of methotrexate (MTX)-5-FU. Thirt

Paclitaxel, cisplatin, and 5-fluorouraci
Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck
✍ Maha Hussain; Shirish Gadgeel; Omer Kucuk; Wei Du; Walter Salwen; John Ensley 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 3 views

## BACKGROUND. The combination of cisplatin and 5-flurouracil (5-FU) is considered standard therapy for patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Paclitaxel has exhibited single-agent activity in patients with this disease. The authors conducted thi